HMGN (Hemagen Diagnostics) Total Assets: $2.44 Mil (As of Sep. 2012)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hemagen Diagnostics Total Assets?

Hemagen Diagnostics HMGN Total Assets is $2.44 Mil as of Sep. 2012.

Hemagen Diagnostics's Total Assets for the quarter that ended in Sep. 2012 was $2.44 Mil.

Total Assets is connected with ROA %. Hemagen Diagnostics's annualized ROA % for the quarter that ended in Sep. 2012 was -26.27%. Total Assets is also linked to Revenue through Asset Turnover. Hemagen Diagnostics's Asset Turnover for the quarter that ended in Sep. 2012 was 0.35.

Hemagen Diagnostics  (OTCPK:HMGN) Total Assets Explanation

Total Assets is connected with ROA %.

Hemagen Diagnostics's annualized ROA % for the quarter that ended in Sep. 2012 is

ROA %=Net Income (Q: Sep. 2012 )/( (Total Assets (Q: Jun. 2012 )+Total Assets (Q: Sep. 2012 ))/ count )
=-0.652/( (2.521+2.443)/ 2 )
=-0.652/2.482
=-26.27 %

Note: The Net Income data used here is four times the quarterly (Sep. 2012) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Hemagen Diagnostics's Asset Turnover for the quarter that ended in Sep. 2012 is

Asset Turnover
=Revenue (Q: Sep. 2012 )/( (Total Assets (Q: Jun. 2012 )+Total Assets (Q: Sep. 2012 ))/ count )
=0.876/( (2.521+2.443)/ 2 )
=0.876/2.482
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Hemagen Diagnostics Total Assets Related Terms

Hemagen Diagnostics Total Assets Historical Data

* Premium members only.

The historical data trend for Hemagen Diagnostics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemagen Diagnostics Total Assets Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.77 3.72 3.37 2.89 2.44

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.89 2.59 2.59 2.52 2.44

Hemagen Diagnostics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Hemagen Diagnostics's Total Assets for the fiscal year that ended in Sep. 2012 is calculated as

Total Assets=Total Equity (A: Sep. 2012 )+Total Liabilities (A: Sep. 2012 )
=-3.557+6
=2.44

Hemagen Diagnostics's Total Assets for the quarter that ended in Sep. 2012 is calculated as

Total Assets=Total Equity (Q: Sep. 2012 )+Total Liabilities (Q: Sep. 2012 )
=-3.557+6
=2.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $2.44 Mil mean?
Hemagen Diagnostics (HMGN) has a Total Assets of $2.44 Mil as of Sep. 2012. The total amount of assets as recorded on a company's balance sheet. View historical data on Hemagen Diagnostics and its competitors.
Is Hemagen Diagnostics' Total Assets too high?
Hemagen Diagnostics' current Total Assets is $2.44 Mil.
How does Hemagen Diagnostics' Total Assets compare to OBMP and NSPX?
Hemagen Diagnostics' Total Assets of $2.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Hemagen Diagnostics and its competitors. Hemagen Diagnostics's current Total Assets is $2.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemagen Diagnostics stock overvalued right now?
Hemagen Diagnostics (HMGN) has a current Total Assets of $2.44 Mil. The current Total Assets is $2.44 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Hemagen Diagnostics (HMGN), the current Total Assets is $2.44 Mil as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hemagen Diagnostics Business Description

Address 9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.